Felix Grant is impressed by a trio of recent add-ons from Maple
At first glance, a laboratory information management system (LIMS) might seem to sit quietly in a laboratory doing its job without really changing. In fact, the reality is far more exciting for this unsung hero of the analytical process, as Siân Harris discovers
Brian Cogan assesses some leading mathematics packages - and finds that an effective comparison is almost impossible
John Murphy profiles Professor Henry Schaefer, a leading light in theoretical computational chemistry at the University of Georgia
Cheaper clusters, multi-core chips, and ever more complex problems to solve mean that the era of desktop supercomputing is upon us. Even Microsoft is getting in on the act, as Tom Wilkie reports
Felix Grant is impressed by a trio of recent add-ons from Maple.
Elsevier and ExactCure recently announced a collaboration to develop and offer to hospitals – without charge – drug-specific exposure models for 20 already approved medicines that are being tested as potential treatments for Covid-19.
With the world’s focus on the COVID-19 pandemic, LIMS providers are working to develop solutions tailored to assist in the testing and management of virus samples.
Researchers at Harvard Medical School (HMS) have released an open source drug discovery platform, VirtualFlow, that harnesses supercomputing power to screen potentially billions of small organic compound structures in parallel, in the hunt for promising new drug molecules.
When designing a component or system, where do you start? In days gone by, designers would literally go back to the drawing board, using their experience and expertise to develop a new concept.
Effective utilisation of computing tools is critical to both AI and HPC research, with recent projects in both fields highlighting the scientific benefit of carefully managing resources.
Advances in computer vision combined with AI computing are helping pathologists to more accurately identify subtypes of cancer - leading to better treatments for patients, explains Dan Ruderman.
